Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: J Thromb Haemost. 2014 May;12(5):690–700. doi: 10.1111/jth.12532

Table 1.

Thrombin-antithrombin (TAT) complex levels in wild-type, endothelial cell protein C receptor (EPCR)-overexpressing and EPCR-deficient mice before and after administration of FVIIa (120 μg kg–1 body weight); blood was drawn prior to FVIIa administration and 1 h after FVIIa administration (n = 10 mice per group)

Genotype TAT complex levels (ng mL –1)
Before FVIIa After FVIIa
Wild type 11.5 ± 0.56 13.7 ± 1.42
EPCR-overexpressing 11.8 ± 1.10 13.2 ± 1.16
EPCR-deficient 11.6 ± 0.37 12.7 ± 0.82